The antitumor effect of extracellular vesicles derived from cytokine-activated CD8+ T cells

J Leukoc Biol. 2024 Nov 4;116(5):1033-1044. doi: 10.1093/jleuko/qiae117.

Abstract

Extracellular vesicles (EVs) are nano-sized membrane particles secreted by various cell types that are involved in many important cellular processes. Recently, EVs originating from immune cells, such as dendritic cells, chimeric antigen receptor T cells, and natural killer cells, have attracted much attention because of their known direct and indirect antitumor activity. Here, we report the EVs released by cytokine-activated CD8+ T (caCD8) cells and its cytotoxicity against cancer cells. CaCD8 cells can release EVs following stimulation of CD8+ T cells with an anti-CD3 antibody and a cytokine cocktail ex vivo. The isolated vesicles have typical EV characteristics, such as an oval shape and a size distribution between 30 and 200 nm, as well as CD81 expression. Notably, caCD8-EVs displayed cytotoxicity against various cancer cells in vitro. Furthermore, mechanism analysis demonstrates that caCD8-EVs not only contain typical cytotoxic proteins (i.e. granzyme B and perforin), but also significantly enrich interferon γ (IFNγ) compared with caCD8 cells. EV-derived IFNγ participates in EV-induced apoptosis in cancer cells. Therefore, our data reveal antitumor effects of EVs secreted from caCD8 cells and the potential role of the EV-derived IFNγ.

Keywords: IFNγ; cytokine-activated CD8+ T cell; cytokine-induced killer cells; cytotoxicity; extracellular vesicles.

MeSH terms

  • Apoptosis
  • CD8-Positive T-Lymphocytes* / immunology
  • Cell Line, Tumor
  • Cytokines / metabolism
  • Cytotoxicity, Immunologic
  • Extracellular Vesicles* / immunology
  • Extracellular Vesicles* / metabolism
  • Humans
  • Interferon-gamma* / metabolism
  • Lymphocyte Activation*
  • Neoplasms / immunology
  • Neoplasms / pathology
  • Neoplasms / therapy

Substances

  • Interferon-gamma
  • Cytokines

Grants and funding